Evidence map›Paper›PMID 25888632›Full record

ArticleOncotarget2015

Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4.

Jae-Wook Lee, Yun-Kyoung Ryu, Young-Hoon Ji, Joo Hyun Kang, Eun-Yi Moon

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Mechanisms of Cell Fusion in Cancer.Results and problems in cell differentiation · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeting Rac and Cdc42 GEFs in Metastatic Cancer.Frontiers in cell and developmental biology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Increased Expression of Thymosin βJournal of pathology and translational medicine · 2017
    Article
  16. Cancer Cell Fusion: Mechanisms Slowly Unravel.International journal of molecular sciences · 2016
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jae-Wook LeeDepartment of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea.
Yun-Kyoung RyuDepartment of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea.
Young-Hoon JiResearch Center for Radiotherapy, Korea Institute of Radiological and Medical Science, Seoul 139-709, Korea.
Joo Hyun KangMolecular Imaging Research Center, Korea Institute of Radiological and Medical Science, Seoul 139-709, Korea.
Eun-Yi MoonDepartment of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea.
Sejong University · KRKorea Institute of Radiological and Medical Sciences · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signaling by small guanosine triphosphatases (GTPase), Rap1/Rac1, is one of the major pathways controlling cancer cell migration and tumor metastasis. Thymosin beta-4 (Tβ4), an actin-sequestering protein, has been shown to increase migration of cancer cells. Episodes of hypoxia and re-oxygenation (H/R) are an important phenomenon in tumor microenvironment (TME). We investigated whether Tβ4 could play as an intermediary to crosstalk between Rac1- and Rap1- GTPase activation under hypoxia/reoxygenation (H/R) conditions. Inhibition of Tβ4 expression using transcription activator-like effector nucleases (TALEN) significantly decreased lung metastasis of B16F10 cells. Rac1 and Rap1 activity, as well as cancer cell migration, increased following induction of Tβ4 expression in normoxia- or H/R-experienced cells, but were barely detectable in Tβ4-depleted cells. Rap1-regulated Rac1 activity was decreased by a dominant negative Rap1 (Rap1N17), and increased by 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (CPT), a Rap1 activator. In contrast, a Rac1-specific inhibitor, NSC23766, and dominant negative Rac1 (Rac1N17) enhanced Tβ4 expression and aberrant Rap1 activity. While NSC23766 and Rac1N17 incompletely inhibited tumor metastasis in vivo, and H/R-experienced cancer cell migration in vitro, more efficient attenuation of cancer cell migration was accomplished by simultaneous inactivation of Rap1 and Rac1 with Rap1N17 and Rac1N17, respectively. These data suggest that a combination therapy targeting both Rap1 and Rac1 activity may be an effective method of inhibiting tumor metastasis.

Indexed as

Gene Expression Regulation, NeoplasticAminoquinolinesAnimalsCell HypoxiaCell Line, TumorCell MovementEnzyme ActivationGTP PhosphohydrolasesHeLa CellsHumansMaleMelanoma, ExperimentalMiceMice, Inbred C57BLNeoplasm MetastasisNeuropeptidesAminoquinolinesGTP PhosphohydrolasesNeuropeptidesNSC 23766OxygenPyrimidinesrac1 GTP-Binding ProteinRAC1 protein, humanRac1 protein, mouseShelterin ComplexTelomere-Binding ProteinsTERF2IP protein, humanThymosinThymosin beta(4)cancer cell migrationRac1-GTPaseRap1-GTPasethymosin beta-4tumor metastasis

Identifiers

PMID25888632
PMCPMC4496400
OpenAlexW2164281914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.